Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07624747 · ClinicalTrials.gov registry record
Brain Health in Transgender Adults
A clinical trial, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- 72
- Enrollment target
NCT07624747 is a clinical trial that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 72 participants.
The verdict
NCT07624747 is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- 72 participants
- Enrollment target
Study Summary
The purpose of this study is to test whether and how a person's brain changes in the first few months after starting gender affirming hormone therapy (GAHT). The investigators want to know if GAHT changes: 1) cerebral blood flow (CBF), 2) brain structure, connectivity, and cognitive task performance, and 3) neurocognitive function (memory, attention, executive function, processing speed). 36 male at birth and 36 female at birth participants will conduct baseline studies prior to GAHT, with a second identical set of study visits 4-6 months after GAHT begins.
Interventions
- DEVICE Magnetic Resonance Imaging
- OTHER Cognition and Health Tests
- OTHER Optional Exercise Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2025-10-14 |
| Est. Completion | 2028-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07624747
The ClinicalTrials.gov registry entry for NCT07624747 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Magnetic Resonance Imaging is the first listed.
NCT07624747 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07624747 about?
NCT07624747 is a clinical study titled "Brain Health in Transgender Adults". The purpose of this study is to test whether and how a person's brain changes in the first few months after starting gender affirming hormone therapy (GAHT). The investigators want to know if GAHT changes: 1) cerebral blood flow (CBF), 2) brain structure, connectivity, and cognitive task performance...
What is the current status of trial NCT07624747?
This trial is currently recruiting. The enrollment target is 72 participants. The study started on 2025-10-14. Estimated completion is 2028-04.
What interventions are being tested in trial NCT07624747?
The interventions under investigation include: Magnetic Resonance Imaging (DEVICE), Cognition and Health Tests (OTHER), Optional Exercise Test (OTHER).
Who is sponsoring clinical trial NCT07624747?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.